Stock & Company Details
Century Therapeutics Inc $IPSC
Price:
N/A
N/A
181M
$404M
52 Week High:
N/A
10 Day Average Volume:
N/A
-1.83
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Non-Energy Minerals
IPSC technical indicators
Latest Century Therapeutics Inc (IPSC) indicator readings as of 2026-08-28.
IPSC's 14-day RSI is 47.1, in neutral territory. At $2.02 it is trading 6.1% above its 200-day moving average of $1.91, and below its 50-day average of $2.16. Price sits in the middle of its Bollinger Bands ($1.85 to $2.20). ADX reads 17.8, indicating a range-bound market rather than a trend.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Century Therapeutics Inc is a biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with a significant unmet medical need. It is assembling a portfolio of allogeneic iNK and iT cell therapy product candidates across solid tumor and hematological malignancies.
Finance Bot
Ask your questions
Start by typing a question below.
